{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:49:21Z","timestamp":1792111761351,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ejpb.2008.12.001","type":"journal-article","created":{"date-parts":[[2008,12,14]],"date-time":"2008-12-14T09:36:12Z","timestamp":1229247372000},"page":"26-33","source":"Crossref","is-referenced-by-count":107,"title":["A freeze-dried formulation of bacteriophage encapsulated in biodegradable microspheres"],"prefix":"10.1016","volume":"72","author":[{"given":"U.","family":"Puapermpoonsiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.F.","family":"van der Walle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2008.12.001_bib1","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0041-1345(03)00525-6","article-title":"Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man","volume":"35","author":"Weber-Dabrowska","year":"2003","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejpb.2008.12.001_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/443754a","article-title":"The road to phage therapy","volume":"443","author":"Adhya","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2008.12.001_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1473-3099(04)01127-2","article-title":"Therapeutic use of bacteriophages","volume":"4","author":"Soothill","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejpb.2008.12.001_bib4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/thorax.58.9.794","article-title":"Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents","volume":"58","author":"Pitt","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.ejpb.2008.12.001_bib5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1090956","article-title":"Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus","volume":"302","author":"Weigel","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2008.12.001_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"Doring","year":"2000","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejpb.2008.12.001_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1569-1993(02)00104-2","article-title":"Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies","volume":"1","author":"Hoiby","year":"2002","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejpb.2008.12.001_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1529-1049(01)00015-0","article-title":"Bacteriophage therapy for infections in cancer patients","volume":"1","author":"Weber-Dabrowska","year":"2001","journal-title":"Clin. Appl. Immunol. Rev."},{"key":"10.1016\/j.ejpb.2008.12.001_bib9","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/AAC.49.7.2874-2878.2005","article-title":"Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy","volume":"49","author":"Bruttin","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2008.12.001_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00003088-200342040-00002","article-title":"Pharmacokinetic principles of bacteriophage therapy","volume":"42","author":"Payne","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2008.12.001_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-4362.2002.01451.x","article-title":"A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds","volume":"41","author":"Markoishvili","year":"2002","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ejpb.2008.12.001_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2230.2004.01600.x","article-title":"The use of a novel biodegradable preparation capable of the sustained release of bacteriophages ciprofloxacin in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90","volume":"30","author":"Jikia","year":"2005","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ejpb.2008.12.001_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jps.21082","article-title":"Engineering biodegradable polyester particles with specific drug targeting and drug release properties","volume":"97","author":"Mohamed","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.12.001_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0939-6411(98)00012-5","article-title":"Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics","volume":"45","author":"Bittner","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2008.12.001_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-3659(97)00241-1","article-title":"Polymeric nanoparticles as delivery system for influenza virus glycoproteins","volume":"54","author":"Lemoine","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2008.12.001_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0168-3659(03)00304-3","article-title":"Encapsulation of protamine sulphate compacted DNA in polylactide and polylactide-co-glycolide microparticles","volume":"92","author":"Dunne","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2008.12.001_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0168-3659(02)00137-2","article-title":"Characterization of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres","volume":"82","author":"Wang","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2008.12.001_bib18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s11095-006-0180-2","article-title":"The influence of surfactant on PLGA microsphere glass transition and water sorption: remodelling the surface morphology to attenuate the burst release","volume":"23","author":"Bouissou","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2008.12.001_bib19","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1126\/science.276.5320.1868","article-title":"Large porous particles for pulmonary drug delivery","volume":"276","author":"Edwards","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2008.12.001_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0168-3659(00)00308-4","article-title":"Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres","volume":"69","author":"Barman","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2008.12.001_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2005.09.007","article-title":"The influence of protein solubilisation, conformation and size on the burst release from poly(lactide-co-glycolide) microspheres","volume":"110","author":"Duncan","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2008.12.001_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jconrel.2003.12.016","article-title":"Controlled release of the fibronectin central cell binding domain from polymeric microspheres","volume":"95","author":"Bouissou","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2008.12.001_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpharm.2005.12.016","article-title":"PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNA","volume":"311","author":"Mohamed","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2008.12.001_bib24","doi-asserted-by":"crossref","DOI":"10.1089\/jamp.2008.0701","article-title":"Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex","volume":"21","author":"Golshahi","year":"2008","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejpb.2008.12.001_bib25","series-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.ejpb.2008.12.001_bib26","series-title":"Physical Pharmacy","first-page":"427","author":"Martin","year":"1993"},{"key":"10.1016\/j.ejpb.2008.12.001_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-3659(00)00227-3","article-title":"Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques","volume":"68","author":"van de Weert","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2008.12.001_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1211\/0022357011775361","article-title":"Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique","volume":"53","author":"Castellanos","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2008.12.001_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/02652040210141093","article-title":"Bioadhesive fluorescent microspheres as visible carriers for local delivery of drugs. I: Preparation and characterization of insulin-loaded PCEFB\/PLGA microspheres","volume":"19","author":"Jiang","year":"2002","journal-title":"J. Microencap."},{"key":"10.1016\/j.ejpb.2008.12.001_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bioeng.2007.02.002","article-title":"A simple two-transition model for loss of infectivity of phages on exposure to organic solvent","volume":"24","author":"Matsubara","year":"2007","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.ejpb.2008.12.001_bib31","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/jps.20364","article-title":"Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and\/or immobilization in a glassy matrix?","volume":"94","author":"Chang","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.12.001_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejpb.2007.03.009","article-title":"Solution formulation and lyophilisation of a recombinant fibronectin fragment","volume":"67","author":"Pereira","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2008.12.001_bib33","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.01513-06","article-title":"Experimental phage therapy against Staphylococcus aureus in mice","volume":"51","author":"Capparelli","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2008.12.001_bib34","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1128\/AEM.67.6.2746-2753.2001","article-title":"Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms","volume":"67","author":"Hanlon","year":"2001","journal-title":"Appl. Environ. Microb."},{"key":"10.1016\/j.ejpb.2008.12.001_bib35","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.vaccine.2003.11.065","article-title":"Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle","volume":"22","author":"Jepson","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2008.12.001_bib36","unstructured":"A.T. Florence, D. Attwood, Macmillan Press, Basingstoke, UK, 1988."},{"key":"10.1016\/j.ejpb.2008.12.001_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0168-3659(95)00051-9","article-title":"The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W\/O\/W solvent evaporation method","volume":"36","author":"Herrmann","year":"1995","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2008.12.001_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/js980423n","article-title":"Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres","volume":"88","author":"Yang","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2008.12.001_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-3659(01)00446-1","article-title":"Effect of protein molecular weight on release from micron-sized PLGA microspheres","volume":"76","author":"Sandor","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2008.12.001_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2005.08.010","article-title":"NMR and confocal microscopy studies of the mechanisms of burst drug release from PLGA microspheres","volume":"108","author":"Messaritaki","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2008.12.001_bib41","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1023\/A:1018868423309","article-title":"Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS)","volume":"16","author":"Ghaderi","year":"1999","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641108004773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641108004773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T16:27:53Z","timestamp":1545582473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641108004773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0939641108004773"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2008.12.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}